RNA structure and function Professors and Supervisors in Germany | ApplySharif

فیلترهای فعال:

جست‌وجوی استاد و پژوهشگر

استاد راهنما، استاد دانشگاه یا پژوهشگر مناسب برای مسیر پژوهشی‌تان را پیدا کنید و با او ارتباط بگیرید.

نمایش ۱۶-۳۰ از ۳۱۶ استاد راهنما

اطلاعات این پروفایل‌ها از صفحات عمومی دانشگاه‌ها جمع‌آوری شده و ممکن است به‌روز نباشد.

Michael Veitمشاهده پروفایل

دانشیار

Free University of BerlinGermany

PD Dr. Michael Veit is an Associate Professor (Privatdozent) at the Institute of Virology, School of Veterinary Medicine, Freie Universität Berlin , where he heads the independent Research Group Veit – Cell Biology of Viral Infections . He is a faculty member of the Center for Infection Medicine and participates in the Berlin Equine Virus Lab (BEVL). Education & Training Doctorate (Dr. rer. nat.) in Virology/Biochemistry – exact institution not stated in text. Post-doctoral qualification (Privatdozent) awarded by Freie Universität Berlin. Research Focus Veit’s laboratory investigates the molecular and cellular biology of enveloped RNA viruses , with emphasis on virus–host membrane interactions and post-translational lipid modifications (S-acylation/palmitoylation). His group combines reverse genetics, live-cell imaging, mass spectrometry and structural approaches to dissect how viral glycoproteins are modified, trafficked and assembled into infectious particles. Model pathogens include influenza A, B, C and D viruses, coronaviruses (SARS-CoV-2, MERS-like CoVs, PHEV, PDCoV), arteriviruses (PRRSV, EAV), alphaviruses (Getah, CHIKV-like), and other emerging zoonotic agents. Publication Trends From 2020 to 2025 Veit has published >30 high-impact articles that cluster around four major themes: (i) coronavirus surveillance and zoonotic risk assessment , (ii) mechanistic dissection of protein acylation in influenza and arteriviruses , (iii) structure-function analysis of viral entry receptors (ACE2, LDLR), and (iv) development of reverse-genetic tools and reporter viruses for antiviral screening. Grants & Collaborative Networks Ongoing third-party funded projects coordinated by Veit are not explicitly listed in the text, but the continuous publication output and mention of “Current Collaborations” imply active grant support. He collaborates closely with other FU Berlin groups (Osterrieder, Kaufer, Azab) and international partners on coronavirus and influenza consortia. Laboratory & Teams The Research Group Veit comprises post-docs, PhD students and technicians working in BSL-2 and BSL-3 facilities at the Institute of Virology. Core platforms include confocal & FLIM microscopy, quantitative proteomics, and reverse-genetics suites for segmented RNA viruses.

پروفایل رسمی دانشگاه

Claudia Crociniمشاهده پروفایل

پژوهشگر

Max Planck Institute for Dynamics and Self-OrganizationGermany

Claudia Crocini is a DZHK junior research group leader at the Max Rubner Center for Cardiovascular Metabolic Renal Research, Charité - Universitätsmedizin Berlin. Her work bridges cardiac physiology, epigenetics, and sex-specific medicine to address critical gaps in cardiovascular research where female hearts have been historically neglected. Her research program centers on sex-dependent differences in human cardiac cells, investigating how biological sex influences contractility, ionic currents, gene expression, and epigenetic regulation. By leveraging induced pluripotent stem cell technology, tissue engineering, and computational modeling, her lab identifies fundamental mechanisms underlying sex-specific cardiac responses to disease. This approach integrates cardiac mechanobiology with molecular analysis to uncover targets for precision medicine. Analysis of her publication record reveals a consistent trajectory toward understanding sex-dimorphic cardiac function, with recent work emphasizing sarcomere mechanics, RNA splicing, and nuclear mechanosensing. Her methodology combines voltage/calcium imaging, contractility assays, and next-generation sequencing to establish sex-specific biomarkers and therapeutic pathways. Dr. Crocini's scientific contributions have been recognized through competitive awards: First prize: Best Postdoc at the MDC (2022) Marie Skłodowska-Curie Fellowship for 'TiGER: Titin can govern epigenetic remodelling' (2021) American Heart Association Postdoc Fellowship (2020) Biophysical Society Travel Award (2020) HSFP Long-Term Fellowship (2017) As principal investigator of her DZHK-funded research group, she directs projects examining sex-dependent cardiac adaptation mechanisms while securing major grants including the Marie Skłodowska-Curie and American Heart Association fellowships. Her work directly addresses the urgent need for sex-inclusive cardiac research to improve clinical outcomes. The Crocini Lab operates within the Max Rubner Center, utilizing stem cell differentiation platforms, engineered cardiac tissues, and advanced imaging to dissect sex-specific cardiac physiology. Current projects focus on translating cellular findings into clinically relevant insights for sex-tailored cardiovascular therapies.

پروفایل رسمی دانشگاه

Andreas Beyerمشاهده پروفایل

استاد

University of CologneGermany

Prof. Dr. Andreas Beyer holds a faculty position at the University of Cologne, affiliated with the Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD) and the Cologne Excellence Cluster for Cellular Mechanisms in Cancer (CMMC). His research focuses on systems-level analysis of aging processes in humans and model organisms, integrating genomic, proteomic, and computational approaches. Key interests include understanding how genetic variation influences protein networks, developing algorithms for big data analysis, and exploring epigenetic mechanisms related to longevity. Research projects include studying age-associated changes in transcriptional elongation, molecular networks in kidney disease, and the impact of dietary restriction on aging. His group develops tools for proteomics and systems biology, such as methods for analyzing limited proteolysis data and single-cell resolution imaging. Collaborative efforts emphasize translational research in aging-related diseases and drug discovery. Prof. Beyer’s work spans computational biology, molecular genetics, and translational medicine. Notable contributions include identifying epigenetic changes linked to longevity and developing predictive models for age-related disease progression. His lab’s projects often involve multi-omics integration and network-based analyses to uncover disease mechanisms. His research has implications for personalized medicine, cancer biology, and interventions to extend healthspan. Current efforts include optimizing drug combinations targeting aging processes and advancing proteomic technologies for clinical applications.

پروفایل رسمی دانشگاه

Christian Freundمشاهده پروفایل

استاد

Heidelberg UniversityGermany

Christian Freund is Professor of Protein Biochemistry at the Institute for Chemistry & Biochemistry, Freie Universität Berlin, holding this W2 professorship since 2011. He serves as Coordinator of the FU Berlin-UCSF Collaborative Initiative and Founding Member/Vice-chair of the DFG Collaborative Research Centre SFB/TRR 186 on Molecular Switches in Cellular Signal Transmission, leading interdisciplinary research across Berlin and Heidelberg institutions. His academic foundation includes Chemistry studies at Heinrich-Heine-Universität Düsseldorf (1983-1986) and Ludwig-Maximilians-Universität München (1986-1989), followed by a PhD in Structural Biology at the Max-Planck-Institute of Biochemistry (1994) and Habilitation in Biochemistry at Freie Universität Berlin (2005). Freund's research integrates structural biology, biophysics, and immunology to investigate molecular mechanisms of antigen presentation and cellular signaling. His work centers on MHC class II dynamics, protein conformational switches, and nanoscale organization of signaling complexes, employing NMR spectroscopy, quantitative proteomics, and molecular engineering to dissect immune recognition pathways and neuronal signaling mechanisms. Analysis of his 2010-2019 publications reveals consistent focus on MHC-mediated antigen presentation (60% of works), with significant contributions to understanding peptide exchange dynamics and HLA-DM editing functions. Secondary research streams explore synaptic protein networks (25%) and T cell signaling machinery (15%), demonstrating methodological breadth across structural biology, proteomics, and cell biological approaches. His scientific recognition includes: Biofuture award from the German Ministry of Education and Research (1999) Swiss National Funds Post-doctoral Scholarship (1997) Innovationswettbewerb Medizintechnik grant (2009) As research group leader at Leibniz-Institute of Molecular Pharmacology (2000-2011) and current FU Berlin professor, Freund has secured major collaborative funding through DFG SFB/TRR 186 and the UCSF partnership. His mentorship spans postdoctoral fellows at Harvard/Dana-Farber and Leibniz-Institute, with current supervision of graduate students in the Berlin biochemistry program. Freund directs a research group within FU Berlin's Institute for Chemistry & Biochemistry, operating as core component of SFB/TRR 186. His laboratory maintains active collaborations with UCSF's QBI (Nevan Krogan) and Heidelberg-based structural biology teams, utilizing advanced NMR, cryo-EM, and single-molecule imaging facilities across the Berlin-Heidelberg research alliance.

پروفایل رسمی دانشگاه

Heike Krebberمشاهده پروفایل

استاد

University of GöttingenGermany

Prof. Heike Krebber is a Professor for Molecular Genetics at Georg-August University Göttingen, Germany. Her research focuses on mRNA quality control and non-coding RNA functions, using the model organism Saccharomyces cerevisiae. She has held positions at the DKFZ (Heidelberg), Harvard Medical School, and Philipps-Universität Marburg. Her work addresses how mRNA processing defects contribute to diseases like cancer and neurodegeneration. Education & Positions: PhD (1996), Deutsches Krebsforschungszentrum Heisenberg Fellow (2006) Habilitation in Molecular Biology (2005) Professor since 2010 at Georg-August University Research Interests: Her lab investigates: RNA quality control mechanisms ensuring proper mRNA maturation and export Functions of non-coding RNAs (e.g., lncRNAs in iron metabolism and telomerase) Ribosome assembly and translation termination pathways Stress-induced bypass of mRNA quality control Awards: Heisenberg Fellowship (2006) Grants & Teams: Leads the Molecular Genetics group at the Institute for Microbiology and Genetics. Collaborates with the IMPRS Molecular Biology and GZMB (Molecular Biology of Cells) programs. Labs & Affiliations: Her group is part of the GGNB network, focusing on Microbiology and Biochemistry. The lab’s work spans fundamental molecular mechanisms with translational disease relevance.

پروفایل رسمی دانشگاه

Johannes Soedingمشاهده پروفایل

پژوهشگر

University of GöttingenGermany

Johannes Soeding is a Research Group Leader in the Computational Biology department at the Max Planck Institute for Multidisciplinary Sciences in Göttingen, Germany. His work bridges physics, bioinformatics, and molecular biology, focusing on computational methods for biological data analysis. His research interests include computational biology, protein structure and function prediction, metagenomics, transcriptional regulation, and statistical genomics. He develops widely used software tools such as HH-suite, HHpred, MMseqs2, and Foldseek for protein sequence and structure analysis. The recent publications demonstrate a strong focus on high-throughput biological data, particularly in protein structure search (e.g., Foldseek), metagenomic gene discovery (e.g., MetaEuk), and regulatory genomics. His work combines algorithm development with deep biological insights, often published in top-tier journals like Nature Biotechnology , Science , and Nature Methods . He has been involved in significant methodological advances in sequence clustering, contact prediction, and eQTL analysis, showing a consistent trend toward scalable, data-driven approaches in genomics and proteomics. Soeding has contributed to major projects in gene regulatory networks and RNA biology, often in collaboration with experimental groups. His leadership in developing open, efficient bioinformatics tools has had a broad impact on the scientific community. He is affiliated with several graduate programs including IMPRS Physics of Biological and Complex Systems, Biomolecules: Structure - Function - Dynamics, and Genome Science, indicating active participation in training the next generation of scientists.

پروفایل رسمی دانشگاه

Felix Jonasمشاهده پروفایل

استادیار

Constructor University BremenGermany

Prof. Dr. Felix Jonas is an Assistant Professor of Biochemistry at the School of Science, Constructor University Bremen, Germany. He leads research on the biochemistry of gene regulation , focusing on molecular mechanisms governing transcription factor function and chromatin dynamics in Saccharomyces cerevisiae . His work integrates CRISPR-Cas9, Next-Generation Sequencing, and computational data analysis. Education: B.Sc. in Molecular Life Sciences (University of Luebeck), M.Sc. in Biology: Cell Biology (ETH Zurich), Ph.D. in Bioengineering (Imperial College London) Work Experience: Postdoc/Senior Postdoc at Weizmann Institute of Science (2017-22), Visiting Student at Weizmann Institute (2015-16), International Program Associate at RIKEN (2011) Teaching: General Biochemistry (CH-100-B), Introduction to Bioinformatics (JTMS-10), Current Topics in Life Sciences (CA-BCCB-801), Advanced Biochemistry II - Molecular Genetics (CO-403-A) His research explores transcription factor target search , histone dynamics , and chromatin structure-function relationships . Recent publications highlight discoveries in nucleosome replacement, protein disorder grammar, and histone acetylation impacts on replication. Articles emphasize interdisciplinary approaches to eukaryotic gene regulation and systems biology. Visit his lab’s PhD recruitment page or watch his Fragile Nucleosome Talk for deeper insights into his work.

پروفایل رسمی دانشگاه

Dirk Schneiderمشاهده پروفایل

استاد

University of MainzGermany

Prof. Dirk Schneider is a Full Professor (W3) of Biochemistry at Johannes Gutenberg University Mainz since 2010, with previous appointments at the University of Freiburg (2003-2009) and postdoctoral training at Yale University. His research spans membrane biochemistry, biophysics, and transmembrane protein folding/assembly, focusing on thylakoid membrane biogenesis and protein-lipid interactions in cyanobacteria and chloroplasts. Current roles: Full Professor, University Mainz Previous roles: Assistant Professor (W1), University of Freiburg Education: PhD (summa cum laude) from Ruhr-University Bochum His research interests include: Membrane protein folding and stability ESCRT-III/Vipp1/PspA family structural dynamics ABC transporter activity regulation (e.g., BmrA) Protein-lipid interaction mechanisms Thylakoid membrane remodeling Comparative membrane biology between prokaryotes and eukaryotes Development of spectroscopic and computational methods Recent publications reveal trends in bacterial membrane remodeling (SynDLP, PspA), lipid effects on transporter activity (BmrA), and IM30/Vipp1-mediated membrane fusion. His work combines structural biology, biophysics, and functional assays to elucidate membrane dynamics. Awarded the Dr. Heinrich Kost Award (2001) and Leopoldina Fellowship (2001) , he has held leadership roles including Study Section Speaker (2010-2014) , Director of Institute of Pharmacy and Biochemistry (2013-2015) , and Dean of Faculty of Chemistry (2015-2020) . His scientific advisory roles include editorial board memberships and study section leadership.

پروفایل رسمی دانشگاه

Zhang Yangمشاهده پروفایل

دانشیار

Helmholtz Institute Ulm for Electrochemical Energy StorageGermany

Artificial Intelligence in Biomedical Imaging
Deep Learning for Omics Data Analysis
Pathogen Detection and Diagnostics
+۷ مورد دیگر

Zhang Yang is an Associate Professor at the School of Medical Engineering, Harbin Institute of Technology (Shenzhen), with a joint appointment as Visiting Professor at the University of Tokyo starting in July 2024. He holds a PhD from the University of Cambridge's Department of Pathology and an M.Phil. from the University of Hong Kong's HKU-Pasteur Research Center. Previously, he served as an Assistant Professor at Harbin Institute of Technology (Shenzhen) from September 2015 to December 2020. His research integrates computational and experimental approaches to address challenges in pathogen and cancer research. On the computational side, his work focuses on developing AI-powered microscopic imaging systems, applying deep learning to analyze multi-omics data (including proteins, DNA, miRNAs, LncRNAs, and mRNAs), and utilizing deep learning in cheminformatics for drug discovery. On the experimental side, his laboratory combines imaging, high-throughput sequencing, mass spectrometry, and chemical biology to understand disease mechanisms at the molecular level. His publication record demonstrates significant impact, with over 50 SCI-indexed papers in high-impact journals including Nature Communications, Briefings in Bioinformatics, Bioinformatics, Analytical Chemistry, and Trends in Biotechnology. His work has been cited by prestigious journals such as Nature Reviews Methods Primers and Nature Communications, with three ESI highly cited papers. His research spans multiple interdisciplinary fields, combining artificial intelligence with biomedical applications to advance diagnostic and therapeutic approaches. World's Top 2% Scientists 2021 Fellow of the Royal Society of Biology Three ESI Highly Cited Papers Five authorized national invention patents As an academic leader, he serves as Associate Editor for BMC Biology and Frontiers in Microbiology, Academic Editor for PLOS Genetics, Editorial Board Member for Communications Biology, and Guest Editor for a Special Issue on AI in analytical chemistry in Trends in Analytical Chemistry. His laboratory actively collaborates with international institutions, with graduates pursuing further studies at Hong Kong Chinese University, Hong Kong University of Science and Technology, Hong Kong Polytechnic University, Macau University, and the University of New South Wales. He teaches Introduction to Modern Biology for undergraduates and Bioanalytical Chemistry for graduate students.

پروفایل رسمی دانشگاه

Henning Urlaubمشاهده پروفایل

استاد

University of GöttingenGermany

Prof. Henning Urlaub is a Professor at the Faculty of Medicine at Georg August University Göttingen and Group Leader of the Bioanalytical Mass Spectrometry Group at the Max Planck Institute for Multidisciplinary Sciences (formerly Max Planck Institute for Biophysical Chemistry). His roles include leading a research group focusing on proteomics and clinical biochemistry at the University Medical Center Göttingen (UMG). He holds dual affiliations in both academic and clinical research sectors. He earned his Ph.D. in biochemistry from the Free University of Berlin (1993–1996) and conducted postdoctoral research at institutions including the Max Delbrück Center for Molecular Medicine (Berlin) and the Philipps University of Marburg. His career includes leadership roles since 2010 in both the Max Planck Institute and UMG. Research Interests : Dr. Urlaub’s work centers on modern mass spectrometry applications for analyzing proteins, post-translational modifications, and protein interactions. Key projects include: Quantitative analysis of synaptic proteins under stimulation Protein cross-linking studies in B cells and other systems Method development for protein-RNA/DNA interactions Structural elucidation of large complexes via CX-MS and cryo-EM His group operates as a core proteomics facility for the Max Planck Institute and collaborates with external institutions like the University Hospital Frankfurt. They also maintain a clinical proteomics branch at the UMG’s Institute for Clinical Chemistry. Collaborations & Infrastructure : The group provides proteomics services to researchers across disciplines, emphasizing translational and clinical applications. Their instrumentation includes advanced mass spectrometry platforms (e.g., ESI, MALDI) for high-throughput proteomic analysis.

پروفایل رسمی دانشگاه

Lennart Randauمشاهده پروفایل

استاد

Max Planck Institute for Terrestrial MicrobiologyGermany

Professor Lennart Randau is a leading researcher in the field of Genetics at Philipps University of Marburg, affiliated with the Faculty of Biology. His work is conducted in conjunction with the Max Planck Institute for Terrestrial Microbiology in Marburg, Germany, where he investigates molecular mechanisms underlying CRISPR-Cas systems and related biotechnological applications. Research focus on CRISPR-Cas evolution and inhibition mechanisms Investigates structural and functional diversity of prokaryotic defense systems Active in developing genome engineering tools from microbial systems His recent publications highlight CRISPR-Cas transitions from natural immunity to synthetic biology applications, with particular emphasis on anti-CRISPR proteins and transposon-associated gene integration mechanisms. Professor Randau's laboratory employs interdisciplinary approaches combining molecular biology, biochemistry, structural biology, and genomics to unravel the complexities of microbial genetic defense systems and their potential applications in biotechnology.

پروفایل رسمی دانشگاه

Tuba Esatbeyogluمشاهده پروفایل

استاد

Leibniz University HannoverGermany

Prof. Dr. Tuba Esatbeyoglu is a full Professor of Molecular Food Chemistry and Development and serves as the Executive Director of the Institute of Food Science and Human Nutrition at Leibniz University Hannover, within the Faculty of Natural Sciences. She leads research in food chemistry, quality, and safety, with a focus on bioactive compounds and sustainable food innovation. Research Interests: Her work centers on secondary plant metabolites, food by-product utilization, HPLC method development, proanthocyanidin chemistry, food stability, authenticity markers, and in vitro biological activity and toxicity. She investigates the bioaccessibility and sensory properties of functional foods, contributing significantly to food quality and safety science. Publication Trends: Her recent publications reflect a strong focus on polyphenols, encapsulation technologies, food waste valorization, and analytical method development. She frequently explores the health impacts of plant extracts, liver protection, and sustainable food systems, often employing in vitro and animal models. Scientific Awards: Georg Forster Research Award (Alexander von Humboldt Foundation, 2022) Poster Prize, Brunel University (2014) Danone Nutrition for Health Institute Scholarships (2013, 2014) Rochow Family Trust Scholarship (2012) DGQ Young Scientist Award (2011) Award for Outstanding Academic Achievements in Food Chemistry (2006) Advising and Grants: While specific students are not listed, she supervises research in food science and has served on examination boards. She has led projects including a genetic engineering S1 facility and holds permissions under the Infection Protection Act. She has been involved in reviewing for major funding bodies including DFG, DAAD, and the Alexander von Humboldt Foundation. Labs and Teams: She heads the Molecular Food Chemistry and Development research group at the Institute of Food Science and Human Nutrition. She is active in national and international scientific networks, including DECHEMA, GDCh, DGE, IFT, and FEI’s Scientific Advisory Board, and contributes to standardization efforts via DIN.

پروفایل رسمی دانشگاه

Susanne Gebhardمشاهده پروفایل

استاد

University of MainzGermany

Prof. Dr. Susanne Gebhard is a Full Professor of Molecular Biotechnology at the Institute for Molecular Physiology , Johannes Gutenberg University (JGU) Mainz, Germany, since 2023. Her career spans international institutions, including postdoctoral work in New Zealand and the UK, and a permanent research and teaching position at the University of Bath. She focuses on bacterial physiology, particularly antibiotic resistance mechanisms and microbially induced calcite precipitation for sustainable biotechnology applications. Education: Abitur (1996), University Degree (2003), PhD in Microbiology (2006, University of Otago, New Zealand), Habilitation (2014) Research Interests: Her work bridges two major themes: Antibiotic Resistance : Investigating how bacteria detect antibiotics and regulate resistance pathways, with implications for novel therapeutic strategies. Microbial Biomineralization : Exploring bacterial mineralization processes to reduce cement usage in construction, addressing CO 2 emissions through Solibacillus silvestris and related species. Publications & Collaborations highlight her expertise in Bacillus subtilis , Pseudomonas , and Neisseria systems, alongside contributions to journals like Nature Communications , Cell Reports , and Environmental Microbiology . She frequently collaborates with labs in Oxford, Cologne, and Australia. Scientific Engagement includes: Senior Editor for the Microbiology journal Deputy Spokesperson for the 'Regulation' specialist group of the Association for General and Applied Microbiology Active participation in international conferences and EMBO workshops Lab & Leadership : She leads the Gebhard Lab at JGU Mainz, mentoring students and postdocs while emphasizing interdisciplinary collaboration. Her hobbies include horseback riding, gardening, and exploring the intersection of science and sustainability.

پروفایل رسمی دانشگاه

Stephanie Panierمشاهده پروفایل

استاد پژوهشی

Max Planck Institute for Biology of AgeingGermany

Dr. Stephanie Panier serves as a Max Planck Research Group Leader at the Max Planck Institute for Biology of Ageing in Cologne, Germany, and as a Principal Investigator at the Institute for Genome Stability in Aging and Disease within the Medical Faculty of the University of Cologne. Her research program investigates the fundamental mechanisms by which cells maintain genome stability through sophisticated DNA damage response pathways. Her academic journey includes: PhD in Molecular Genetics from the University of Toronto (2008-2013) under Prof. Daniel Durocher Postdoctoral training at the Francis Crick Institute in London (2013-2019) with Prof. Simon Boulton Undergraduate studies in Biology at Ruprecht-Karls-Universität Heidelberg, Germany (2001-2006) Dr. Panier's laboratory focuses on two central questions in genome stability research: how DNA damage response pathways interact with telomere maintenance mechanisms, and how RNAs and RNA-binding proteins organize chromatin-based responses to DNA lesions. Her team employs cutting-edge cell biological and omics approaches to identify and characterize RNA-binding proteins at DNA damage sites, mapping their chromatin dynamics and interactions following genotoxic stress. This research has significant implications for understanding aging-associated diseases driven by genomic instability, including cancer and neurodegeneration. Analysis of her publication record reveals consistent contributions to understanding DNA repair mechanisms, with recent work expanding into cancer biology, telomere maintenance in alternative lengthening pathways, and the emerging role of RNA metabolism in genome stability. Her scientific achievements have been recognized through: Vivash Award for best PhD thesis (2013) FEBS Excellence Award (2023) EMBO Long-Term Fellowship (2013-2014) Vanier Canada Graduate Scholarship (2010-2013) Boehringer Ingelheim Fonds PhD Fellowship (2008-2010) EIRR21st Fellowship (2023) Dr. Panier actively contributes to the scientific community through leadership roles including Vice Coordinator of the DFG Research Unit FOR5504 (2023-2026), membership on the advisory board of the German Society for Research on DNA Repair since 2022, and representation on the Biology and Medicine Section of the Max Planck Society's scientific council since 2022. She also serves as a Principal Investigator in the Cologne Excellence Cluster 'Cellular Stress Responses in Aging-Associated Diseases' (CECAD). Her laboratory comprises postdoctoral researchers and PhD students working collaboratively to advance our understanding of genome stability mechanisms in aging, with current projects focusing on RNA-binding proteins in DNA damage response and telomere maintenance pathways.

پروفایل رسمی دانشگاه

Ines Krohnمشاهده پروفایل

پژوهشگر

University of HamburgGermany

Dr. Ines Krohn is a Research Group Leader at the University of Hamburg's Faculty of Mathematics, Informatics and Natural Sciences, specifically within the Department of Microbiology & Biotechnology. She leads the "Algae-Bacteria Interactions" research group, focusing on marine and environmental microbiology with biotechnological applications. University of Hamburg (2010-2013): Diploma in Biology University of Hamburg (2013): Dr. rer. nat. in Biology Her research spans two primary areas: 1) Utilizing aquatic and marine resources for biotechnology, particularly through metagenomic analysis of microalgal-bacterial communities to discover novel biomolecules and 2) investigating molecular mechanisms in microalgae-bacteria interactions, including biofilm formation and cell-cell communication. Current projects include MarBioTech (marine biodiversity exploration), AimM (biofilm monitoring), AquaHealth (aquaculture disease prevention), and SuReMetS (marine nutraceuticals for metabolic syndrome). Her publication record demonstrates expertise in metagenomics , biofilm inhibition , microalgal biotechnology , marine enzyme discovery , and antimicrobial applications . Notable collaborations include work with Prof. Wolfgang R. Streit and teams at Hagenbeck Zoo. She actively supervises bachelor's and master's candidates and offers thesis opportunities in metagenomics and biofilm research. Her laboratory explores both fundamental microbial interactions and applied biotechnologies , including biofilm disruption strategies for medical and industrial applications. Specific techniques include RNAseq, functional screening, and enzyme characterization from marine sources.

پروفایل رسمی دانشگاه